Thein KZ, Htut TW, Ball S, Swarup S, et al. Venous thromboembolism risk in patients with hormone receptor-positive
HER2-negative metastatic breast cancer treated with combined CDK 4/6 inhibitors
plus endocrine therapy versus endocrine therapy alone: a systematic review and
meta-analysis of rand Breast Cancer Res Treat 2020 Jul 9. pii: 10.1007/s10549-020-05783.
PMID: 32647939